Niloufar Javanmardi

Publication Activity (10 Years)

Years Active: 2017-2017
Publications (10 Years): 1

Top Topics

Epidermal Growth Factor Receptor

Epithelial Mesenchymal Transition

Magnetic Resonance

Advanced Non Small Cell Lung Cancer

Top Venues

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Ganesh Umapathy, Jikui Guan, Dan Emil Lind, Niloufar Javanmardi, Diana Cervantes-Madrid, Anna Djos, Tommy Martinsson, Ruth H Palmer, Bengt Hallberg
MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas. Science signaling 10 (507) (2017)